Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: l-arginine supplementation alternative to lysine-restricted diet
- 1 November 2014
- journal article
- case report
- Published by Elsevier BV in European Journal of Paediatric Neurology
- Vol. 18 (6), 741-746
- https://doi.org/10.1016/j.ejpn.2014.07.001
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Lysine restricted diet for pyridoxine-dependent epilepsy: First evidence and future trialsMolecular Genetics and Metabolism, 2012
- Long-term follow-up in two siblings with pyridoxine-dependent seizures associated with a novel ALDH7A1 mutationEuropean Journal of Paediatric Neurology, 2011
- Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicityChemico-Biological Interactions, 2011
- Long‐term follow‐up and treatment in nine boys with X‐linked creatine transporter defectJournal of Inherited Metabolic Disease, 2011
- Diagnosis and management of glutaric aciduria type I – revised recommendationsJournal of Inherited Metabolic Disease, 2011
- Aldehyde Dehydrogenase 7A1 (ALDH7A1) Is a Novel Enzyme Involved in Cellular Defense against Hyperosmotic StressOnline Journal of Public Health Informatics, 2010
- Folinic acid–responsive seizures are identical to pyridoxine‐dependent epilepsyAnnals of Neurology, 2009
- Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+American Journal of Physiology-Endocrinology and Metabolism, 2006
- Pipecolic Acid as a Diagnostic Marker of Pyridoxine-Dependent EpilepsyNeuropediatrics, 2005
- The Importance of Cationic Amino Acid Transporter Expression in Human SkinJournal of Investigative Dermatology, 2003